Importantly, both tumor cells and infiltrating macrophages in aggressive HIV-associated DLBCLs have been shown to express the checkpoint molecule programmed cell death ligand 1 (PD-L1) [100,101], highlighting the potential utility of immune checkpoint inhibitors targeting the PD-1/PD-L1 axis in this context. This evidence concerns the gene CD274 and neoplasm.